menu close
www.abatatx.com

Abata Therapeutics Stock

Company Profile:

Abata Therapeutics focuses on developing innovative therapies for autoimmune diseases by leveraging the biology of regulatory T cells. The company is advancing autologous Treg cell therapies to stop immune system damage, restore balance, and promote tissue repair, with an emphasis on treating conditions like multiple sclerosis.

Sign up for SecondMarket® to view the market and buy or sell Abata Therapeutics Stock
Buy + Sell
  • Headquarters: Watertown, MA
  • Year Founded: 2015
  • Sector: Health Care
Leverage Your Equity to Help Achieve More.

Abata Therapeutics Management Team

  • Board Member

    Lorence Kim

  • CTO

    Joanne Beck

  • COO

    John Trzupek

  • Board Member, President, CEO

    Samantha Singer

  • Chief People Officer

    Sandy Lazzari

  • Board Member

    Abbie Celniker

  • Board Member

    Mitch Finer

  • Board Member

    Valerie Odegard

  • Board Member

    Shelley Chu

  • Chief Medical Officer

    Leonard Dragone

  • Board Member

    Nagesh Mahanthappa

  • Chief Scientific Officer

    Ellen Cahir-Mcfarland

  • Board Member

    David Kaufman

Learn More About Abata Therapeutics Stock

Buy Abata Therapeutics Stock
01

Abata Therapeutics stock does not trade on public stock exchanges. Abata Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Abata Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Abata Therapeutics Stock
02

Abata Therapeutics Stock does not trade on public stock exchanges. In order to sell Abata Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Abata Therapeutics Stock Price
03

Abata Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Abata Therapeutics share price and other valuable private market data.

Read more about secondary market private company stock prices:

Abata Therapeutics Stock Ticker Symbol
04

There is no ticker symbol for Abata Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Abata Therapeutics Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Abata Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Abata Therapeutics Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Abata Therapeutics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Abata Therapeutics Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Abata Therapeutics IPO
08

Abata Therapeutics is a private company and has not had an IPO. There is currently no Abata Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Abata Therapeutics IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell Abata Therapeutics Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Insitro-Logo

insitro

Drug discovery and development company.

Lyra Healthcare-Logo

Lyra

Digital health startup using technology to connect companies and employees to mental health providers.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Tonal Strong-Logo

Tonal

Developed a fitness system, called Tonal, that combines revolutionary equipment, expert-led videos, and personalized guidance into full body workouts users can do on demand from the convenience of home.

Curology-Logo

Curology

Offers personalized prescription skin care medications delivered directly to you.

Devoted

Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.

Benchling-Logo

Benchling

Cloud based platform for research and development in biotechnology.

Cityblock Health-Logo

Cityblock Health

Tech-driven care provider for communities with complex needs.

Cerebral

Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

Source: Nasdaq Private Market Tape D®